Sign in
4

Changes in Ownership

NORTHWEST BIOTHERAPEUTICS INC Filed Acc 0001144204-17-032807

Options or other derivatives

  • Chief Scientific Officer acquired 3,402,935 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
BOYNTON ALTON L Chief Scientific Officer 2017-06-13 Grant or award · Employee Stock Option (Right to Buy) +3,402,935 3,402,935 D
Loading xslF345X03/v469119_4.xml…